MedTrace Logo

A Study of Atropine Sulfate in Healthy Chinese Volunteers

NCT05855018 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-11

No results posted yet for this study

Summary

To evaluate the systemic pharmacokinetics and the safety of atropine sulfate eye drops in healthy volunteers.

Conditions

  • Pharmacokinetics

Interventions

DRUG

Atropine sulfate eye drops

One drop once daily

Sponsors & Collaborators

  • Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited

    lead INDUSTRY

Principal Investigators

  • Christopher LEUNG · HKU Eye Centre

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855018 on ClinicalTrials.gov